Key result
A bioadaptive nanomedicine sequentially delivering NAD+ and genipin promoted functional cardiac recovery after myocardial infarction through mitochondrial protection and metabolic repair.
Answers are grounded in this paper and cite their sources.
A novel bioadaptive nanomedicine delivering NAD+ and genipin shows promise for metabolic repair and functional recovery after myocardial infarction.
After myocardial infarction, injured myocardium enters a highly dynamic metabolic state that is difficult to treat with a single intervention. A study now reports a bioadaptive nanomedicine that sequentially delivers NAD+ and genipin, coordinating mitochondrial protection and metabolic repair to promote functional recovery of the heart.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question. A bioadaptive nanomedicine sequentially delivering NAD+ and genipin promoted functional cardiac recovery after myocardial infarction through mitochondrial protection and metabolic repair.
Synapse has enriched 10 related papers. Consider them for comparative context: